» Articles » PMID: 8985096

Photobleaching of Protoporphyrin IX in Cells Incubated with 5-aminolevulinic Acid

Overview
Journal Int J Cancer
Specialty Oncology
Date 1997 Jan 6
PMID 8985096
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Protoporphyrin IX (Pp IX) is the main photosensitizer in photochemotherapy with 5-aminolevulinic acid (ALA). Pp IX is photolabile and the present work shows that 70-95% of Pp IX in cells is degraded by clinically relevant light exposures (40-200 J cm(-2) at 630 nm). During light exposure a small yield of photoprotoporphyrin, which is also photolabile, is formed. A substantial fraction of Pp IX in cells incubated with ALA is bound to proteins. During light exposure these binding sites are destroyed, those close to tryptophan residues being the most sensitive. The rate of photodegradation of Pp IX in the cells is dependent on the initial concentration of Pp IX. The degradation mechanisms are therefore not only first order processes. Different degradation rates appear to be related to different types of binding sites. During light exposure, Pp IX molecules appear to move to different binding sites, evidently sites that are more vital for cell survival. Thus, the yield of photoinactivation of the cells, as measured per emitted photon of Pp IX fluorescence, increased during light exposure.

Citing Articles

The effect of fluence rate and wavelength on the formation of protoporphyrin IX photoproducts.

Ogbonna S, Masuda K, Hazama H Photochem Photobiol Sci. 2024; 23(9):1627-1639.

PMID: 39244727 DOI: 10.1007/s43630-024-00611-9.


Current Advances in Photodynamic Therapy (PDT) and the Future Potential of PDT-Combinatorial Cancer Therapies.

Alvarez N, Sevilla A Int J Mol Sci. 2024; 25(2).

PMID: 38256096 PMC: 10815790. DOI: 10.3390/ijms25021023.


Increased fluorescence observation intensity during the photodynamic diagnosis of deeply located tumors by fluorescence photoswitching of protoporphyrin IX.

Ogbonna S, York W, Nishimura T, Hazama H, Fukuhara H, Inoue K J Biomed Opt. 2023; 28(5):055001.

PMID: 37197689 PMC: 10185104. DOI: 10.1117/1.JBO.28.5.055001.


Advances in Liposome-Encapsulated Phthalocyanines for Photodynamic Therapy.

Rak J, Kabesova M, Benes J, Pouckova P, Vetvicka D Life (Basel). 2023; 13(2).

PMID: 36836662 PMC: 9965606. DOI: 10.3390/life13020305.


The Effects of 5% 5-Aminolevulinic Acid Gel and Red Light (ALAD-PDT) on Human Fibroblasts and Osteoblasts.

Pierfelice T, DAmico E, Petrini M, Pandolfi A, DArcangelo C, Di Pietro N Gels. 2022; 8(8).

PMID: 36005091 PMC: 9407194. DOI: 10.3390/gels8080491.